Public Employees Retirement System of Ohio lessened its stake in Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) by 26.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 31,603 shares of the company’s stock after selling 11,300 shares during the period. Public Employees Retirement System of Ohio owned 0.17% of Addus HomeCare worth $3,640,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of ADUS. BI Asset Management Fondsmaeglerselskab A S bought a new position in Addus HomeCare in the 1st quarter worth approximately $41,000. Caitong International Asset Management Co. Ltd raised its position in shares of Addus HomeCare by 368.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company’s stock valued at $124,000 after acquiring an additional 987 shares during the last quarter. GAMMA Investing LLC raised its position in shares of Addus HomeCare by 26.4% during the 2nd quarter. GAMMA Investing LLC now owns 1,673 shares of the company’s stock valued at $193,000 after acquiring an additional 349 shares during the last quarter. Bailard Inc. bought a new stake in shares of Addus HomeCare during the 1st quarter valued at $208,000. Finally, Heritage Family Offices LLP raised its position in shares of Addus HomeCare by 6.3% during the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company’s stock valued at $239,000 after acquiring an additional 143 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.
Insider Buying and Selling
In related news, EVP Brian Poff sold 7,739 shares of the company’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $116.82, for a total value of $904,069.98. Following the completion of the transaction, the executive vice president directly owned 56,980 shares of the company’s stock, valued at approximately $6,656,403.60. This represents a 11.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the completion of the transaction, the chief executive officer directly owned 166,461 shares of the company’s stock, valued at approximately $19,134,691.95. The trade was a 13.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,310 shares of company stock valued at $3,958,375. Company insiders own 4.50% of the company’s stock.
Addus HomeCare Price Performance
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its earnings results on Monday, August 4th. The company reported $1.49 earnings per share for the quarter, topping analysts’ consensus estimates of $1.45 by $0.04. The firm had revenue of $349.44 million during the quarter, compared to analyst estimates of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The company’s revenue for the quarter was up 21.8% compared to the same quarter last year. During the same period in the prior year, the business earned $1.35 EPS. Research analysts predict that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several brokerages have commented on ADUS. Macquarie reiterated an “outperform” rating and set a $133.00 target price on shares of Addus HomeCare in a research report on Tuesday, June 10th. TD Cowen upped their target price on shares of Addus HomeCare from $135.00 to $139.00 and gave the company a “buy” rating in a research report on Wednesday, August 6th. Stephens reiterated an “overweight” rating and set a $140.00 target price on shares of Addus HomeCare in a research report on Wednesday, September 3rd. UBS Group began coverage on shares of Addus HomeCare in a research report on Tuesday, September 2nd. They set a “buy” rating and a $145.00 target price for the company. Finally, JMP Securities reiterated a “market outperform” rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Wednesday, July 16th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $138.89.
Check Out Our Latest Report on Addus HomeCare
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- Trading Stocks: RSI and Why it’s Useful
- PayPal Stock: Why Wall Street May Be Undervaluing This Giant
- Should You Invest in Penny Stocks?
- Why Vertical Aerospace Could Lead the eVTOL Market by 2028
- What is an Earnings Surprise?
- Is Draganfly’s Army Partnership a Game-Changer for Investors?
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.